The global cannabis testing market was valued at around USD 1.35 billion in 2021 and is estimated to grow to about USD 10.86 billion by 2028, with a compound annual growth rate (CAGR) of approximately 19.8 percent over the forecast period.
The global cannabis testing market was valued at around USD 1.35 billion in 2021 and is estimated to grow to about USD 10.86 billion by 2028, with a compound annual growth rate (CAGR) of approximately 19.8 percent over the forecast period. The report analyzes key drivers and opportunities that support the market growth along with the cannabis testing market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cannabis testing market.
Cannabis Testing Market: Overview
Cannabis testing is the process of analyzing a single sample of cannabis to evaluate CBD, THC, and terpene levels, as well as pollutants and impurities such as mold spores, residual solvents, infection, and pesticide residue. Each state and municipality has the authority to set their own rules and regulations for what must be tested and printed on cannabis labeling. Individual producers may also choose to adhere to more severe guidelines, even having their samples tested for CBG and CBC levels. Only qualified chemists and lab workers are permitted to conduct this testing. Cannabis production and sales were formerly prohibited worldwide for numerous years.
The unforeseen COVID-19 pandemic has had both beneficial and bad consequences for the life sciences and pharma industries. Low demand for consumables, instruments, and reagents, along with supply chain disruptions and trade limitations, have harmed certain market sectors more than others. According to a report issued by The Science Advisory Board, 72.0 percent of all labs throughout the world were shut down or operating at a reduced capacity. Instead of doing routine operations, the labs that were open fully or partially focused on COVID-19 testing. Many participants in the industry have seen their operations and financial performance suffer as a result of the epidemic and slowed worldwide research activity. The number of cannabis tests done in laboratories has decreased as a result of the closure of academic and research institutes as well as testing facilities.
Cannabis Testing Market: Growth Drivers
The market is fostering with medical cannabis legalization and increasing cannabis testing labs
Medical cannabis has shown to be helpful in a number of medical uses, including lowering intraocular pressure in glaucoma patients, managing muscular spasms in multiple sclerosis patients, boosting appetite in AIDS patients, and minimizing chemotherapy-induced nausea. Medical cannabis is legal in a number of countries due to its health benefits. Italy, Brazil, Israel, the Netherlands, Germany, the United Kingdom, Portugal, Spain, North Korea, Canada, and Australia have all approved it in the last few years. Furthermore, 25 states in the United States legalized medical cannabis, with four states—Alaska, Oregon, Washington, and Colorado legalizing cannabis for use for both recreational and medical purposes. Thus, with the rising legalization of cannabis, an increase in adoption of its testing is been witnessed which in turn is fostering the growth of the global cannabis testing market. In addition to this, the increasing number of cultivators and the growing necessity for the safety & efficacy of cannabis products are also some of the key factors that are fueling the market growth.
Cannabis Testing Market: Restraints
The cannabis testing market may be hampered by a lack of universal testing standards.
For delivering a precise and accurate dose of cannabis for medical purposes, certain standards of quality control and regulation are essential. There is, however, a lack of consistency in quality standards among countries. For example, different states in the United States have varied rules and variances governing medical and adult-use cannabis. Various states have different possession limits. The wide range of legislation governing the use of medical cannabis presents a considerable problem for testing laboratories when assessing the quality of these products. Such disparities between states in the United States and between European countries may stymie business growth.
Cannabis Testing Market: Opportunities
Growing necessity of heavy metal testing for cannabis is likely to drive the market during the forecast period.
Besides pesticides, microbiological organisms, and residual solvents, heavy metals are one of the most common pollutants detected in cannabis and its derivatives. Furthermore, heavy metals are highly poisonous and can cause poisoning and other issues when exposed. As a result, heavy metal testing for cannabis and its derivatives is becoming extremely prevalent. Several government agencies have made heavy metal testing for cannabis products mandatory. All such factors coupled with the use of advanced instruments like HPLC techniques are likely to generate ample opportunities for the growth of the global cannabis testing market during the forecast period.
Cannabis Testing Market: Challenges.
High cost associated with the set-up of cannabis testing laboratories acts as a major challenge for the market
One of the most critical challenges in this market is the high startup expenses for cannabis testing laboratories. These labs must invest a large amount of money in order to purchase and maintain expensive, modern analytical equipment. Accreditations & certifications such as ISO certification processes, software requirements, standardization & upgrades of equipment, and the need for qualified experts all add to the operating costs. Also, because of the ambiguity in the cannabis testing market, many banks refuse to fund or provide any other type of support to these laboratories. Furthermore, several governments are working on a plan to impose taxes on cannabis testing labs. Thus, the high cost associated with the set-up of cannabis testing laboratories poses a major challenge for the market growth.
Cannabis Testing Market: Segmentation
The global cannabis testing market is divided based on technology, test type, and region. Based on the technology, the global market is split into spectroscopy and chromatography. By test type, the market is categorized into mycotoxin testing, terpene testing, heavy metal testing, residual solvent screening, pesticide screening, and potency testing.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Cannabis Testing Market: Regional Landscape
North America to dominate the market during the forecast period
Geographically, North America is estimated to dominate the global cannabis testing market during the forecast period. The existence of a significant number of cultivators in the region, as well as an increase in the number of testing laboratories in the region due to strict government restrictions for cannabis producers, are key drivers promoting market growth in this region. Europe, on the other hand, is anticipated to grow at the fastest rate during the forecast period. The rising legalization of cannabis in several European countries, as well as the expanding use of the plant in drug development & research, are expected to fuel the market for cannabis testing. In addition, the cannabis testing market in the region is tightly regulated, with most countries barring goods having more than 0.3 percent THC, thereby driving the market growth in this region.
Cannabis Testing Market: Competitive Landscape
Some of the dominant players that are functioning in the global cannabis testing market are Thermo Fisher Scientific, MERCK KGAA, Shimadzu Corporation, Agilent Technologies, Inc., PharmLabs LLC, SC Laboratories, Inc., Steep Hill Inc., DigiPath, Inc., GreenLeaf Lab, and CW ANALYTICAL, among others.
Global cannabis testing market is segmented as follows:
By Test Type
Cannabis is a type of psychoactive drug that has recreational and medicinal uses. Cannabis mainly consists of THC (tetrahydrocannabinol) that causes changes in perception, increases appetite and sensation of euphoria. There are different types of cannabis, such as topical cannabis, inhaling cannabis, solid edible cannabis, and liquid edible cannabis, which are tested during the cannabis testing procedure.
The increase in the use of medical cannabis for various applications, such as reduction of nausea caused after chemotherapy, stimulation of appetite in patients suffering from AIDS, and controlling of muscle spasms, is fueling the demand for cannabis globally. This increase in demand has led to the legalization of cannabis by governments in various countries. For instance, Australia legalized medical cannabis in 2016, which is fuelling the growth of the global cannabis testing market. The rise in adoption of the cannabis software namely LIMS in the cannabis testing labs and the rise in the number of awareness programs such as workshops and conferences in various countries is also driving the global market for cannabis testing. However, the high cost of instruments and the lack of skilled professionals are hampering the development of the global cannabis testing market.
The global cannabis testing market can be divided based on product and software, a method of testing, and end-users. Based on product and software, this market can be classified into products and software. The product segment is further divided into analytical instruments, which includes spectroscopy instruments, chromatography instruments, and others, and consumable includes standards and CRMS, chromatography columns, sample preparation products, and supplies and accessories. In 2017, the product segment acquired the largest market share. On the basis of the method of testing, this market can be categorized into potency, pesticide screening, microbial analysis, genetic, heavy metal, residual solvent screening, and terpene profiling. The potency segment is anticipated to dominate the market in the forecast timeframe. Based on end-users, the cannabis testing market can be fragmented into research institutions, cannabis testing laboratories, drug manufacturers and dispensaries, and cultivators. The cannabis testing laboratories segment is projected to lead the end-user segment of the cannabis testing market in the forecast timeframe.
North America is projected to lead the cannabis testing market in the upcoming years, due to the legalization of cannabis by major states in the U.S. and Canada and the presence of major market players. Asia Pacific region is anticipated to show the highest growth rate for cannabis testing market. The rise in the use of cannabis to treat diseases, growing awareness about cannabis among the population in developing countries, and an increase in the number of cannabis testing labs are driving the growth of the cannabis testing market in the Asia Pacific region.
The main players in the global cannabis testing market are AB Sciex LLC, Agilent Technologies, Inc., Waters Corporation, CannaSys, Inc., Shimadzu Corporation, GenTech Scientific, Millipore Sigma, PerkinElmer, Inc., PharmLabs, LLC, and Cannabix Technologies, Inc. These companies focus on the introduction of new technologies that can be used for cannabis testing. For instance, in November 2016, Waters Corporation introduced CORTECS Shield RP18 and CORTECS T3, which are used to analyze complex samples at low costs.